Depression Clinical Trials in Illinois

47 recruiting studies across 1 city

Browse by City

All Trials in Illinois

Phase

Trial	Phase	Sponsor	Dist.
E-Mindfulness Approaches for Living After Breast Cancer	Phase 3	NRG Oncology	2 mi
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses	Phase 2	Reunion Neuroscience Inc	2 mi
My Wellbeing Guide: A Novel Tool for Managing Stress and Improving Quality of Life	N/A	Northwestern University	2 mi
"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"	Phase 3	Cybin IRL Limited	2 mi
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder	Phase 3	Cybin IRL Limited	2 mi
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression	N/A	LivaNova	2 mi
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms	Phase 3	Janssen Research & Development, LLC	2 mi
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder	Phase 2	Syndeio Biosciences, Inc	2 mi
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms	Phase 4	Axsome Therapeutics, Inc.	2 mi
Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services	—	Beth Israel Deaconess Medical Center	2 mi
Our Voices Matter: Intervention for Depression in Youth	N/A	Ann & Robert H Lurie Children's Hospital of Chicago	2 mi
Hybrid Type 1 Randomized Pilot Trial of a Peer-led Family and Social Strengthening Group Intervention for Refugee Families	N/A	University of Illinois at Chicago	2 mi
Fostering Optimal Regulation of Emotion for Prevention of Secondary Trauma (FOREST)	N/A	Northwestern University	2 mi
Digital InteGrated Behavioral TreatmeNt for Comorbid ObesITy and DeprEssion Among Racial and Ethnic Adults Age 50 and Older	N/A	University of Illinois at Chicago	2 mi
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder	Phase 3	Xenon Pharmaceuticals Inc.	2 mi
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients	Phase 3	Intra-Cellular Therapies, Inc.	2 mi
Test of Target Engagement of Ambiguity Aversion	N/A	Northwestern University	2 mi
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder	Phase 3	Vanda Pharmaceuticals	2 mi
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder	Phase 2	AbbVie	2 mi
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)	Phase 2	atai Therapeutics, Inc.	2 mi
Study of ALTO-300 in MDD	Phase 2	Alto Neuroscience	2 mi
Developing Evidence-Based Cognitive Approaches to Improve Adjustment to Vision Loss	N/A	The Chicago Lighthouse	2 mi
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.	Phase 3	AbbVie	2 mi
Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis	N/A	University of Illinois at Chicago	2 mi
Evaluating the Impact of Focused Muscle Contraction Therapy in U.S. Veterans	N/A	University of Illinois at Chicago	2 mi
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)	N/A	Abbott Medical Devices	2 mi
A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder	Phase 2	AbbVie	2 mi
ACE-D Aim 3 Clinical Cognitive Trial to Enhance Translation in Depression	Phase 2	Stanford University	2 mi
Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.	Phase 2	LB Pharmaceuticals Inc.	2 mi
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol	Phase 3	Axsome Therapeutics, Inc.	2 mi
Community-based Approach to Lowering Stress Through Mindfulness	N/A	Northwestern University	2 mi
A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression	Phase 2	Draig Therapeutics Ltd	2 mi
Effects of Transcutaneous Vagal Nerve Stimulation on Post-Surgical Return to Consciousness, Delirium, and Depression	N/A	Northwestern University	2 mi
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder	Phase 3	Janssen Research & Development, LLC	2 mi
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)	Phase 3	Definium Therapeutics US, Inc.	2 mi
Clemastine for Improving White Matter and Boosting Antidepressant Response in Late-life Depression	Phase 2	University of Illinois at Chicago	2 mi
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)	Phase 2	Tonix Pharmaceuticals, Inc.	2 mi
Developing a Digital Intervention for Adolescent Nonsuicidal Self-injury	N/A	Northwestern University	2 mi
Transition Care for FEP	—	University of Chicago	2 mi
A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder	Phase 3	Janssen Research & Development, LLC	12 mi
Experimental Evidence of the Impact of Parental Income on Child Mental Health and Neuroimmune Function	N/A	Northwestern University	12 mi
A Study of Esketamine Nasal Spray Versus Placebo Spray in Adult Participants With Treatment-resistant Depression	Phase 3	Janssen Research & Development, LLC	12 mi
A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)	Phase 3	Xenon Pharmaceuticals Inc.	21 mi
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)	Phase 3	Xenon Pharmaceuticals Inc.	21 mi
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor	Phase 4	Neurocrine Biosciences	27 mi
Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)	Phase 2	Autobahn Therapeutics, Inc.	35 mi
Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder	Phase 2	Syndeio Biosciences, Inc	35 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.